Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.
about
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancerGenetic Variation of Fatty Acid Oxidation and Obesity, A Literature ReviewSirtuins as regulators of metabolism and healthspanStructure and function of biotin-dependent carboxylasesNovel roles of holocarboxylase synthetase in gene regulation and intermediary metabolismLipocalin 13 regulation of glucose and lipid metabolism in obesityParameter trajectory analysis to identify treatment effects of pharmacological interventionsSilencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease.Ananas comosus L. Leaf Phenols and p-Coumaric Acid Regulate Liver Fat Metabolism by Upregulating CPT-1 Expression.Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cellsCarnitine Palmitoyltransferase 1b Deficiency Protects Mice from Diet-Induced Insulin ResistanceBrain transcriptional responses to high-fat diet in Acads-deficient mice reveal energy sensing pathways.Genome-wide analysis of cold adaptation in indigenous Siberian populations.Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice.Acetylated and propionated derivatives of swertiamarin have anti-adipogenic effects.Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.CD47 deficiency protects mice from diet-induced obesity and improves whole body glucose tolerance and insulin sensitivity.Flavonoid ingredients of Ginkgo biloba leaf extract regulate lipid metabolism through Sp1-mediated carnitine palmitoyltranferase 1A up-regulationChronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen.Genes involved in sex pheromone biosynthesis of Ephestia cautella, an important food storage pest, are determined by transcriptome sequencing.Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis.Multiparity leads to obesity and inflammation in mothers and obesity in male offspring.Analysis of the Agrotis segetum pheromone gland transcriptome in the light of sex pheromone biosynthesis.Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice.The n-3 long-chain PUFAs modulate the impact of the GCKR Pro446Leu polymorphism on triglycerides in adolescents.Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation.Piceatannol Exerts Anti-Obesity Effects in C57BL/6 Mice through Modulating Adipogenic Proteins and Gut Microbiota.Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats.Rifampicin-Induced Hepatic Lipid Accumulation: Association with Up-Regulation of Peroxisome Proliferator-Activated Receptor γ in Mouse LiverAssociation of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach.Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.Oleic acid stimulates complete oxidation of fatty acids through protein kinase A-dependent activation of SIRT1-PGC1α complex.Circadian control of oscillations in mitochondrial rate-limiting enzymes and nutrient utilization by PERIOD proteins.Mitochondrial fission induced by platelet-derived growth factor regulates vascular smooth muscle cell bioenergetics and cell proliferation.Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.Emerging options in the treatment of dyslipidemias: a bright future?Curcumin and liver disease.Steatosis in the liver.Elevated expression of fatty acid synthase and nuclear localization of carnitine palmitoyltransferase 1C are common among human gliomas.AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistance
P2860
Q26747750-CDA0E21F-B8D2-4C60-90E6-5AC7604C3B43Q26749062-90822542-0CA8-4078-B788-76C3BCA77051Q26828939-9BBCC25B-C4DA-4069-AA59-31622F6DD40FQ26851762-4AAFEEA7-0F39-43B2-A962-1680D6CC43A2Q26864754-EEB1515E-FE78-4B50-A5F3-BA3BA790826CQ26996675-33C562BD-4C4F-4B8E-B048-6F947E7476B1Q28535030-80DFA42C-E2AF-4651-8B51-5B327816D8BAQ33862990-1FFBC2EC-44EC-4A57-8539-4AFB8FDFDEF5Q34093727-DD9D7A9A-9294-4B19-A62E-08268F73DA68Q34245749-C0393CAE-C950-4806-88DF-85937B27EC96Q34307835-E36CAC22-1798-4BB5-A4BA-207A762D6C81Q34398831-7192992F-96C4-4CA8-A664-B345A0653E72Q34420852-31DFFA32-579A-418C-B5D3-CF8AC681A766Q34442261-869DA315-BD24-4124-A162-4BE7EC07CF18Q34509083-61FC8911-F5DE-49AF-9DFD-38A874BAF105Q34647400-0F29CE2B-868F-4F10-BD41-0E3725C2CF3BQ35157350-0D271253-EC29-4E2B-A41F-8C8C9B776DF5Q35596837-A8F53F68-8B6F-44F3-B732-91892F4B5D89Q35624869-56F7C2B3-AD71-4F60-961D-6EEF0D747074Q35695830-A256F5C3-FA5D-4780-99E9-22413A134F7EQ35752074-211B051F-D32D-4A9D-B517-585A5764CF63Q35780719-809EB32F-B54E-4C4F-B8F1-06F986106CDBQ35781038-834F5A3E-20F5-4445-8DAD-EE6CA7A00DB0Q35823390-A45FA96A-F1A9-4EA5-BA09-09131E75E596Q35994377-53357857-A55C-4A29-AE74-49A2EE308A12Q36014621-57E56C9F-86BE-4D7C-A492-EAFAD30AC35FQ36176999-48A70D23-910D-4950-959B-B32040D7DED1Q36179973-C2611E73-C815-470D-BD0C-434CF671FF04Q36180478-A395B8B6-96CD-4A34-A598-F421C2AB3927Q36251303-A3EB9949-B73D-4FD8-8191-C375130FB862Q36503839-D36F95E2-9B7A-4DFD-AA42-728C59B4ADAEQ36666210-58197740-3292-4BE7-A9D1-CE3611F72A52Q36742789-0365F3BB-FFF7-4985-ACBB-E05DB7B4BA1BQ37331731-30FD0F2D-A8B9-44E5-887B-63FDF1DA4A7FQ37734673-29216AF3-225D-40DA-BD3D-E2D9A9BF3694Q37842462-B81899DA-D1A5-43B7-9D10-57D4056EA424Q38072883-8168D355-295B-402B-B0F8-D3A3B1139025Q38165140-B5B1628B-DAC3-49A1-B999-904AD1A690E9Q38979044-5D7467B7-4648-449B-8EFD-677F3FAD7395Q39137705-F764E4F5-1C7C-44D0-9AAF-C428666DC71C
P2860
Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Regulatory enzymes of mitochon ...... ent of the metabolic syndrome.
@ast
Regulatory enzymes of mitochon ...... ent of the metabolic syndrome.
@en
Regulatory enzymes of mitochon ...... ent of the metabolic syndrome.
@nl
type
label
Regulatory enzymes of mitochon ...... ent of the metabolic syndrome.
@ast
Regulatory enzymes of mitochon ...... ent of the metabolic syndrome.
@en
Regulatory enzymes of mitochon ...... ent of the metabolic syndrome.
@nl
prefLabel
Regulatory enzymes of mitochon ...... ent of the metabolic syndrome.
@ast
Regulatory enzymes of mitochon ...... ent of the metabolic syndrome.
@en
Regulatory enzymes of mitochon ...... ent of the metabolic syndrome.
@nl
P2093
P2860
P1433
P1476
Regulatory enzymes of mitochon ...... ent of the metabolic syndrome.
@en
P2093
F R van der Leij
M Schreurs
P2860
P304
P356
10.1111/J.1467-789X.2009.00642.X
P577
2009-08-20T00:00:00Z